Evidence map›Paper›PMID 22277078›Full record

ArticleVeterinary research2012

Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88).

Roger Badia, Galliano Zanello, Claire Chevaleyre, Rosil Lizardo, François Meurens, Paz Martínez, Joaquim Brufau, Henri Salmon

Open access · goldAbstract read
In one paragraph

Article in Veterinary research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Antibiotics (Basel, Switzerland) · 2021
    Article
  8. Gut health: The results of microbial and mucosal immune interactions in pigs.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2021
    Review
  9. Review
  10. Article
  11. Journal of fungi (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Effects of prebiotics on immune system and cytokine expression.Medical microbiology and immunology · 2017
    Review
  16. Influence ofClinical and experimental gastroenterology · 2016
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Roger BadiaInstitut de Recerca i Tecnologia Agroalimentàries, Animal Production, IRTA, Constantí, Spain. roger.badia@irta.cat.
Galliano Zanello
Claire Chevaleyre
Rosil Lizardo
François Meurens
Paz Martínez
Joaquim Brufau
Henri Salmon
Infectiologie Animale et Santé Publique · FRInstitute for Research and Technology in Food and Agriculture · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotic and prebiotics, often called "immune-enhancing" feed additives, are believed to deal with pathogens, preventing the need of an immune response and reducing tissue damage. In this study, we investigated if a recently developed β-galactomannan (βGM) had a similar protective role compared to Saccharomyces cerevisiae var. Boulardii (Scb), a proven probiotic, in the context of enterotoxigenic Escherichia coli (ETEC) infection. ETEC causes inflammation, diarrhea and intestinal damage in piglets, resulting in large economic loses worldwide. We observed that Scb and βGM products inhibited in vitro adhesion of ETEC on cell surface of porcine intestinal IPI-2I cells. Our data showed that Scb and βGM decreased the mRNA ETEC-induced gene expression of pro-inflammatory cytokines TNF-α, IL-6, GM-CSF and chemokines CCL2, CCL20 and CXCL8 on intestinal IPI-2I. Furthermore, we investigated the putative immunomodulatory role of Scb and βGM on porcine monocyte-derived dendritic cells (DCs) per se and under infection conditions. We observed a slight up-regulation of mRNA for TNF-α and CCR7 receptor after co-incubation of DC with Scb and βGM. However, no differences were found in DC activation upon ETEC infection and Scb or βGM co-culture. Therefore, our results indicate that, similar to probiotic Scb, prebiotic βGM may protect intestinal epithelial cells against intestinal pathogens. Finally, although these products may modulate DC activation, their effect under ETEC challenge conditions remains to be elucidated.

Indexed as

PrebioticsAdaptive ImmunityAnimal FeedAnimalsBacterial AdhesionChemokinesCytokinesDendritic CellsEnterotoxigenic Escherichia coliGalactoseImmunity, InnateIntestinal MucosaMaleMannansProbioticsReal-Time Polymerase Chain ReactionChemokinesCytokinesgalactomannanGalactoseMannansPrebiotics

Identifiers

PMID22277078
PMCPMC3305624
OpenAlexW2116291394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.